Mounjaro Cost in 2026: Price, Coverage, and Savings

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Anyone typing "cheapest Mounjaro" into a search bar is really asking a bundle of separate questions at once: what the drugmaker lists it at, what a plan will shoulder, which cards apply, and whether a compounded route exists. Mounjaro — Eli Lilly's dual-incretin injectable first cleared for type 2 diabetes — sits at the top of that price curiosity. The PlexusDx Education Hub breaks the number down piece by piece so the quotes you see online stop looking so contradictory.

The sticker price, and why it's only a starting point

Eli Lilly's published U.S. list price for Mounjaro is roughly $1,069 a month as of April 2026. That headline is the amount before insurance rebates, savings cards, and pharmacy negotiation ever touch it — a reference point, not a prediction of your receipt. Most insured patients pay a fraction of it, which is why cash quotes and insured quotes can look like they're describing two different medications.

Coverage: the diabetes versus weight divide

The single biggest swing factor is the indication on your prescription. Commercial plans commonly cover GLP-1 receptor agonists for type 2 diabetes, Mounjaro's original approval. Weight-management coverage is where things fracture — many plans layer on BMI-based prior authorization, and some exclude the category altogether. Medicare does not pay for FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular indications can follow different rules. Confirm specifics with your own plan.

Savings cards and discount marketplaces

Lilly publishes a commercial savings card that can pull the monthly figure down substantially for patients with eligible private insurance; Medicare, Medicaid, and TRICARE enrollees are typically carved out. Because the cards carry caps and change without much notice, verify current terms at fill time. Independent tools like GoodRx and SingleCare post their own cash prices, which vary pharmacy to pharmacy and are worth comparing side by side.

Where compounded tirzepatide stands after the shortage

During the FDA-declared shortages, licensed 503A pharmacies were allowed to compound semaglutide and tirzepatide. The agency marked the semaglutide shortage resolved in late 2024 and the tirzepatide shortage resolved in early 2025, narrowing that lane without eliminating legitimate compounding for patient-specific needs. Compounded tirzepatide is not identical to brand Mounjaro, is not a generic, and is priced on its own terms.

Realistic monthly outcomes

Put together, a few patterns emerge. With a covered indication and an active card, eligible patients may see as little as $25 a month within the card's limits. Without indication coverage, you land near list price minus any coupon. Uninsured, you approach the full $1,069 unless a discount card helps. And the compounded protocols inside the PlexusDx Weight Management Protocols — including Tirzepatide Injection — publish their own per-product pricing.

Why two people rarely respond the same way

PlexusDx offers semaglutide and tirzepatide directly, but its starting point sits upstream of the pharmacy. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, surfacing trait-level variants such as GLP1R and TCF7L2 that shape baseline incretin signaling and glucose handling. It doesn't forecast your reaction to any specific medication — it hands you and your provider a clearer read on the biology you bring to the conversation.

Questions worth raising with your prescriber and pharmacy

Because so much of the final price hinges on paperwork, a few targeted questions can save real money. Ask your prescriber which indication they plan to document and whether your plan requires prior authorization for it. Ask the pharmacy to run both your insurance and any discount card so you can see which produces the lower figure for that fill. If cost is a barrier, ask whether the compounded route is clinically appropriate for you. None of these steps change the underlying list price, but together they often change the amount you actually pay — and they're worth working through before your first fill rather than after.

Questions worth raising with your prescriber and pharmacy

Because so much of the final price hinges on paperwork, a few targeted questions can save real money. Ask your prescriber which indication they plan to document and whether your plan requires prior authorization for it. Ask the pharmacy to run both your insurance and any discount card so you can see which produces the lower figure for that fill. If cost is a barrier, ask whether the compounded route is clinically appropriate for you. None of these steps change the underlying list price, but together they often change the amount you actually pay — and they are worth working through before your first fill rather than after.

Related PlexusDx reading: Mounjaro cost in 2026, Mounjaro side effects, and Mounjaro injection. To begin with your genetics rather than a price sheet, take the Precision Peptide Genetic Test.

Frequently Asked Questions About Mounjaro Cost

What is Mounjaro's list price in 2026?

Eli Lilly lists Mounjaro at roughly $1,069 per month in the U.S. as of April 2026. That is the pre-adjustment figure; insurance, a manufacturer savings card, and pharmacy-level pricing can move your actual out-of-pocket cost well below it. Confirm the current price with your pharmacy before filling.

Will my insurance treat Mounjaro as a diabetes drug?

It depends on the indication your prescriber documents and your plan's formulary. GLP-1 receptor agonists for type 2 diabetes are widely covered; weight-management use is more variable and often needs prior authorization. Medicare excludes weight-alone indications as of April 2026. Check your specific plan for details.

Is compounded tirzepatide the same as Mounjaro?

No. Compounded tirzepatide from a licensed 503A pharmacy is legally and factually distinct from brand Mounjaro, is not a generic, and skips the FDA manufacturing review the brand undergoes. It remains available for patient-specific needs where clinically justified, at pricing separate from the brand.

How low can the price actually go?

With a covered indication and an active Lilly savings card, eligible commercially insured patients may pay as little as $25 monthly within the card's caps. Those without indication coverage or insurance pay closer to list price minus any discount-card savings. Terms change, so verify before each fill.

Keep exploring the PlexusDx Education Hub for more on GLP-1 pricing, coverage, and the genetics behind metabolic response.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.